TMDX | TransMedics GroupNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$67.34
+$0.67 (+1.00%)

TransMedics Group (TMDX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $67.34 vs 50 $80.57 / 200 $93.72
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Apr 2026 ยท projected 28 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $67.34 vs 50 $74.48 / 200 $79.18
Projection
No cross projected
Test
No active test
Last cross
Death cross 23 Oct 2026 ยท projected 30 bars out

Cross history

21
crosses on record since 2020
10 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Oct 2026Death4-hour30 bars outNot tested
25 Aug 2026Golden4-hour30 bars outNot tested
15 Apr 2026Death steepdaily28 bars outNot tested
20 Mar 2026Death4-hour20 bars outNot tested
3 Nov 2025Golden4-hour16 bars out4 bar cross test

About TMDX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$59.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.